For healthcare professionals and facilitiesPatients and families: buy The Breather direct →
Study summary · AJSLP 2026

49% lower 30-day readmission rate in a COPD hospital pilot.

One hospital's 30-day rate fell 14.4% to 7.3% (2019 to 2022).

Review the evidence

Impact of a respiratory muscle strength training program on hospital readmissions in patients with COPD: a retrospective pilot study. Vora J, Morey S. American Journal of Speech-Language Pathology, 2026. Retrospective pilot study. doi:10.1044/2026_AJSLP-25-00613

What does it mean? Plain-language article → Read the full study on the journal site →

What they did

A speech-language pathology team at a rural acute-care hospital ran a year-long RMT program in 2022 for adults admitted with COPD exacerbations. Patients got inspiratory and expiratory RMT, starting during the admission.

How they compared it

30-day readmissions in the program year were compared with a pre-program year (2019) at the same hospital, and with a comparable hospital in the same system that didn't run the program. They used two-proportion z tests and effect sizes. Feasibility and cost were described, not tested.

What they reported

66patients completed in-hospital training
14.4% → 7.3%30-day readmissions, 2019 vs 2022
0adverse events reported

That's a 7.1-percentage-point absolute and 49.3% relative reduction. It was not statistically significant within the site. 2022 readmissions were significantly lower than at the comparison hospital.

What the authors concluded

Starting SLP-led RMT during a COPD admission appears feasible and cost-effective, and is associated with a promising reduction in readmissions. Given the retrospective design and the non-significant within-site comparison, causal conclusions cannot be drawn. They call for prospective research.

Read these numbers with their limits

  • Retrospective design: one hospital's records, 2022 vs a historical 2019 year. Not randomized.
  • Within-site change was not statistically significant (7.1-point absolute, 49.3% relative reduction).
  • 2022 readmissions were significantly lower than at the comparison hospital in the same system.
  • The authors state that causal conclusions cannot be drawn and call for prospective studies.
  • The abstract describes inhale-and-exhale RMT. It does not name a device.

Take the study to your team

A specialist covers the study, its limits and practical setup in a staff in-service.

Request a staff in-service

Read the study's limits, summarized above.

Try the free breathing test →

Source: published abstract.

Follow the breath – new every week.LinkedInYouTubeTikTokInstagramFacebookX